Literature DB >> 2452082

Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates.

R Gentz1, U Certa, B Takacs, H Matile, H Döbeli, R Pink, M Mackay, N Bone, J G Scaife.   

Abstract

Plasmodium falciparum merozoites are covered with polymorphic proteins that are processed from a 190 kd (p190) precursor protein. These are candidates for an antimalarial vaccine. We cloned and expressed a number of DNA fragments, comprising almost the entire p190 gene of the K1 isolate, in Escherichia coli. Pooled human endemic-area sera and rabbit antibodies raised against p190 protein isolated from K1 parasites react with only a limited number of the recombinant proteins. From these studies we could select two antigenic polypeptides containing conserved amino acid stretches of the otherwise highly polymorphic protein. Rabbits and mice injected with the purified recombinant proteins produce antibodies reacting differentially with various isolates of P. falciparum. We obtained antibodies detecting all isolates tested and a monoclonal antibody specific for isolates containing a K1 type allele of the p190 gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452082      PMCID: PMC454261          DOI: 10.1002/j.1460-2075.1988.tb02803.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Plasmodium falciparum: characterization of defined antigens by monoclonal antibodies.

Authors:  L H Perrin; E Ramirez; L Er-Hsiang; P H Lambert
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

3.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

5.  Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli.

Authors:  E Amann; J Brosius; M Ptashne
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies.

Authors:  R Hall; J McBride; G Morgan; A Tait; J W Zolg; D Walliker; J Scaife
Journal:  Mol Biochem Parasitol       Date:  1983-03       Impact factor: 1.759

9.  Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites.

Authors:  R R Freeman; A A Holder
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

10.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

Authors:  A A Holder; R R Freeman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more
  13 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population.

Authors:  D J Conway; B M Greenwood; J S McBride
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Stowers; D Taylor; N Prescott; Q Cheng; J Cooper; A Saul
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli.

Authors:  Martin Hammarström; Niklas Hellgren; Susanne van Den Berg; Helena Berglund; Torleif Härd
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

Review 5.  Malaria vaccine.

Authors:  U Certa
Journal:  Experientia       Date:  1991-02-15

6.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass.

Authors:  R R Taylor; D B Smith; V J Robinson; J S McBride; E M Riley
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.

Authors:  L Kabilan; V P Sharma; P Kaur; S K Ghosh; R S Yadav; V S Chauhan
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection.

Authors:  M A Herrera; F Rosero; S Herrera; P Caspers; D Rotmann; F Sinigaglia; U Certa
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

9.  Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum.

Authors:  H M Etlinger; P Caspers; H Matile; H J Schoenfeld; D Stueber; B Takacs
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  One-step purification of recombinant proteins with the 6xHis tag and Ni-NTA resin.

Authors:  J Crowe; B S Masone; J Ribbe
Journal:  Mol Biotechnol       Date:  1995-12       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.